A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease

When international treatment guidelines are strictly followed, Crohn's disease patients can achieve high rates of remission and low rates of morbidity at 5 years. Indiscriminate use of biologic agents therefore is not appropriate for all patients with moderate-to-severe disease.